Search

Eric K. Nicholson

Examiner (ID: 1800)

Most Active Art Unit
3501
Art Unit(s)
3508, 3642, 2899, 3744, 3501, 3627, 3629, 3626, PQT, 3679
Total Applications
2110
Issued Applications
1732
Pending Applications
114
Abandoned Applications
263

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7581100 [patent_doc_number] => 20110294983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'SINGLE-CHAIN ANTIPARALLEL COILED COIL PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/133309 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16647 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294983.pdf [firstpage_image] =>[orig_patent_app_number] => 13133309 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/133309
SINGLE-CHAIN ANTIPARALLEL COILED COIL PROTEINS Dec 7, 2009 Abandoned
Array ( [id] => 6289430 [patent_doc_number] => 20100158808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Altered Activity of Toll-Like Receptors' [patent_app_type] => utility [patent_app_number] => 12/633392 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15697 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158808.pdf [firstpage_image] =>[orig_patent_app_number] => 12633392 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/633392
Altered Activity of Toll-Like Receptors Dec 7, 2009 Abandoned
Array ( [id] => 6476791 [patent_doc_number] => 20100285016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'PRO34128 nucleic acids' [patent_app_type] => utility [patent_app_number] => 12/592121 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 36808 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285016.pdf [firstpage_image] =>[orig_patent_app_number] => 12592121 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/592121
PRO34128 nucleic acids Nov 18, 2009 Abandoned
Array ( [id] => 9254844 [patent_doc_number] => 08618262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Monoclonal antibodies against dendritic cell receptor' [patent_app_type] => utility [patent_app_number] => 12/591412 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 8916 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12591412 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/591412
Monoclonal antibodies against dendritic cell receptor Nov 17, 2009 Issued
Array ( [id] => 10050828 [patent_doc_number] => 09090695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Antibodies for guanylyl cyclase receptors' [patent_app_type] => utility [patent_app_number] => 13/132493 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 31 [patent_no_of_words] => 34480 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132493 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/132493
Antibodies for guanylyl cyclase receptors Nov 16, 2009 Issued
Array ( [id] => 7662696 [patent_doc_number] => 20110311965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'METHODS OF ENHANCING TRANSLOCATION OF CHARGED ANALYTES THROUGH TRANSMEMBRANE PROTEIN PORES' [patent_app_type] => utility [patent_app_number] => 13/129278 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23212 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311965.pdf [firstpage_image] =>[orig_patent_app_number] => 13129278 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/129278
METHODS OF ENHANCING TRANSLOCATION OF CHARGED ANALYTES THROUGH TRANSMEMBRANE PROTEIN PORES Nov 12, 2009 Abandoned
Array ( [id] => 7501703 [patent_doc_number] => 20110263585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Screening Assay for Insecticides' [patent_app_type] => utility [patent_app_number] => 13/127505 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 74618 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263585.pdf [firstpage_image] =>[orig_patent_app_number] => 13127505 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/127505
Screening assay for insecticides Nov 4, 2009 Issued
Array ( [id] => 7509919 [patent_doc_number] => 20110256122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/130656 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21234 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256122.pdf [firstpage_image] =>[orig_patent_app_number] => 13130656 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/130656
POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS Nov 3, 2009 Abandoned
Array ( [id] => 6625303 [patent_doc_number] => 20100034817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/574818 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 42985 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034817.pdf [firstpage_image] =>[orig_patent_app_number] => 12574818 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/574818
COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES Oct 6, 2009 Abandoned
Array ( [id] => 6368130 [patent_doc_number] => 20100074905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/560637 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58116 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074905.pdf [firstpage_image] =>[orig_patent_app_number] => 12560637 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/560637
METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS Sep 15, 2009 Abandoned
Array ( [id] => 6497646 [patent_doc_number] => 20100093988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NUCLEIC ACID ENCODING RECEPTOR TYPE PROTEIN KINASE' [patent_app_type] => utility [patent_app_number] => 12/557193 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7053 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093988.pdf [firstpage_image] =>[orig_patent_app_number] => 12557193 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/557193
NUCLEIC ACID ENCODING RECEPTOR TYPE PROTEIN KINASE Sep 9, 2009 Abandoned
Array ( [id] => 4500666 [patent_doc_number] => 07919465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Peptide mimotopes that inhibits interaction between a platelet receptor and a platelet receptor ligand' [patent_app_type] => utility [patent_app_number] => 12/546811 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 12571 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919465.pdf [firstpage_image] =>[orig_patent_app_number] => 12546811 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/546811
Peptide mimotopes that inhibits interaction between a platelet receptor and a platelet receptor ligand Aug 24, 2009 Issued
Array ( [id] => 5970608 [patent_doc_number] => 20110151485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'METHOD FOR SCREENING FOR ANTIANGIOGENIC AGENT, AND METHOD FOR SCREENING FOR ANTIANGIOGENIC SIGNAL GENE' [patent_app_type] => utility [patent_app_number] => 13/060753 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8061 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20110151485.pdf [firstpage_image] =>[orig_patent_app_number] => 13060753 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/060753
METHOD FOR SCREENING FOR ANTIANGIOGENIC AGENT, AND METHOD FOR SCREENING FOR ANTIANGIOGENIC SIGNAL GENE Aug 23, 2009 Abandoned
Array ( [id] => 7711820 [patent_doc_number] => 20120004172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'SCREENING METHOD OF ANTI-LUNG OR ESOPHAGEAL CANCER COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/125549 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28262 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125549 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/125549
SCREENING METHOD OF ANTI-LUNG OR ESOPHAGEAL CANCER COMPOUNDS Aug 23, 2009 Abandoned
Array ( [id] => 7586388 [patent_doc_number] => 20110280898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/059617 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12875 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280898.pdf [firstpage_image] =>[orig_patent_app_number] => 13059617 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/059617
INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME Aug 13, 2009 Abandoned
Array ( [id] => 6622995 [patent_doc_number] => 20100003722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'PRODUCTION AND PURIFICATION OF IL-29' [patent_app_type] => utility [patent_app_number] => 12/537935 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36757 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003722.pdf [firstpage_image] =>[orig_patent_app_number] => 12537935 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/537935
Production and purification of IL-29 Aug 6, 2009 Issued
Array ( [id] => 8220799 [patent_doc_number] => 20120135002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Compounds and Methods for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 13/383847 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7055 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383847 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/383847
Compounds and Methods for the Treatment of Cancer Jul 15, 2009 Abandoned
Array ( [id] => 6351816 [patent_doc_number] => 20100021950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/502674 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21408 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021950.pdf [firstpage_image] =>[orig_patent_app_number] => 12502674 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/502674
SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS Jul 13, 2009 Abandoned
Array ( [id] => 8066197 [patent_doc_number] => 20110243923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/133464 [patent_app_country] => US [patent_app_date] => 2009-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 21463 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243923.pdf [firstpage_image] =>[orig_patent_app_number] => 13133464 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/133464
Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands Jul 11, 2009 Issued
Array ( [id] => 6162741 [patent_doc_number] => 20110160081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => ' FUNCTIONAL COMPLEMENTATION ASSAY FOR DEFINED GPCR OLIGOMERS' [patent_app_type] => utility [patent_app_number] => 13/000613 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23507 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160081.pdf [firstpage_image] =>[orig_patent_app_number] => 13000613 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/000613
FUNCTIONAL COMPLEMENTATION ASSAY FOR DEFINED GPCR OLIGOMERS Jun 30, 2009 Abandoned
Menu